Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Zuber

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Current Opinion in Genetics & Development|April 6, 2019
Functional-genetic approaches to understanding drug response and resistanceMatthias Hinterndorfer, Johannes Zuber
Experimental Hematology|February 4, 2011
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent mannerTimothy S Pardee, Johannes Zuber, Scott W Lowe
Molecular Therapy. Methods & Clinical Development|July 17, 2024
Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cellsGina Blahetek, Christine Mayer, Johannes Zuber, et al.
Nature Communications|February 11, 2018
The IAP family member BRUCE regulates autophagosome-lysosome fusionPetra Ebner, Isabella Poetsch, Luiza Deszcz, et al.
Human Gene Therapy Methods|January 13, 2018
Pooled Generation of Lentiviral Tetracycline-Regulated microRNA Embedded Short Hairpin RNA LibrariesFelix F Adams, Thomas Hoffmann, Johannes Zuber, et al.
Oncotarget|October 15, 2016
MEK1 is required for the development of NRAS-driven leukemiaJoanna D Nowacka, Christian Baumgartner, Cristiana Pelorosso, et al.
Experimental Cell Research|July 17, 2018
TCEA1 regulates the proliferative potential of mouse myeloid cellsTaomei Yang, Haoran Cui, Mingxin Wen, et al.
Cell Reports|May 4, 2017
STAT3 Regulation of Citrate Synthase Is Essential during the Initiation of Lymphocyte Cell GrowthSarah MacPherson, Michael Horkoff, Cleo Gravel, et al.
Scientific Reports|June 22, 2021
A genome-wide CRISPR/Cas9 screen to identify phagocytosis modulators in monocytic THP-1 cellsBenjamin Lindner, Eva Martin, Monika Steininger, et al.
Frontiers in Immunology|October 3, 2022
Comprehensive CRISPR-Cas9 screen identifies factors which are important for plasmablast developmentTheresa Pinter, Maria Fischer, Markus Schäfer, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Current Opinion in Genetics & Development|April 6, 2019
Functional-genetic approaches to understanding drug response and resistanceMatthias Hinterndorfer, Johannes Zuber
Experimental Hematology|February 4, 2011
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent mannerTimothy S Pardee, Johannes Zuber, Scott W Lowe
Molecular Therapy. Methods & Clinical Development|July 17, 2024
Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cellsGina Blahetek, Christine Mayer, Johannes Zuber, et al.
Nature Communications|February 11, 2018
The IAP family member BRUCE regulates autophagosome-lysosome fusionPetra Ebner, Isabella Poetsch, Luiza Deszcz, et al.
Human Gene Therapy Methods|January 13, 2018
Pooled Generation of Lentiviral Tetracycline-Regulated microRNA Embedded Short Hairpin RNA LibrariesFelix F Adams, Thomas Hoffmann, Johannes Zuber, et al.
Oncotarget|October 15, 2016
MEK1 is required for the development of NRAS-driven leukemiaJoanna D Nowacka, Christian Baumgartner, Cristiana Pelorosso, et al.
Experimental Cell Research|July 17, 2018
TCEA1 regulates the proliferative potential of mouse myeloid cellsTaomei Yang, Haoran Cui, Mingxin Wen, et al.
Cell Reports|May 4, 2017
STAT3 Regulation of Citrate Synthase Is Essential during the Initiation of Lymphocyte Cell GrowthSarah MacPherson, Michael Horkoff, Cleo Gravel, et al.
Scientific Reports|June 22, 2021
A genome-wide CRISPR/Cas9 screen to identify phagocytosis modulators in monocytic THP-1 cellsBenjamin Lindner, Eva Martin, Monika Steininger, et al.
Frontiers in Immunology|October 3, 2022
Comprehensive CRISPR-Cas9 screen identifies factors which are important for plasmablast developmentTheresa Pinter, Maria Fischer, Markus Schäfer, et al.
Pageof 17